|
1
|
Dexamethasone and hypoxia upregulate CXCR4 expression in myeloma cells.
|
Leuk Lymphoma
|
2009
|
1.48
|
|
2
|
Clinical efficacy of mitoxantrone and Ara-C with or without etoposide salvage chemotherapy in adult patients with relapsed or refractory acute lymphoblastic leukemia: retrospective multicenter study of the Korean Adult ALL Working Party.
|
Acta Haematol
|
2014
|
1.38
|
|
3
|
Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry.
|
Int J Hematol
|
2013
|
1.14
|
|
4
|
Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party.
|
Int J Hematol
|
2010
|
0.96
|
|
5
|
Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α.
|
Oncol Rep
|
2012
|
0.95
|
|
6
|
Prognostic implications of the immunophenotype in biphenotypic acute leukemia.
|
Leuk Lymphoma
|
2008
|
0.92
|
|
7
|
Production of stromal cell-derived factor-1 (SDF-1)and expression of CXCR4 in human bone marrow endothelial cells.
|
J Korean Med Sci
|
2003
|
0.91
|
|
8
|
Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases.
|
Korean J Hematol
|
2011
|
0.90
|
|
9
|
A multicenter retrospective analysis of adverse events in Korean patients using bortezomib for multiple myeloma.
|
Int J Hematol
|
2006
|
0.89
|
|
10
|
Direct and indirect effects of androgens on survival of hematopoietic progenitor cells in vitro.
|
J Korean Med Sci
|
2005
|
0.88
|
|
11
|
Osteopetrotic mouse stroma with thrombopoietin, c-kit ligand, and flk-2 ligand supports long-term mobilized CD34+ hematopoiesis in vitro.
|
Stem Cells Dev
|
2005
|
0.87
|
|
12
|
Downregulation of APE1/Ref-1 is involved in the senescence of mesenchymal stem cells.
|
Stem Cells
|
2009
|
0.87
|
|
13
|
The CXCR4 Antagonist AMD3100 Has Dual Effects on Survival and Proliferation of Myeloma Cells In Vitro.
|
Cancer Res Treat
|
2010
|
0.86
|
|
14
|
Expression regulation and function of Pref-1 during adipogenesis of human mesenchymal stem cells (MSCs).
|
Biochim Biophys Acta
|
2009
|
0.85
|
|
15
|
Overexpression of stromal cell-derived factor-1 enhances endothelium-supported transmigration, maintenance, and proliferation of hematopoietic progenitor cells.
|
Stem Cells Dev
|
2006
|
0.85
|
|
16
|
Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma Registry.
|
Acta Haematol
|
2009
|
0.85
|
|
17
|
Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia.
|
Transfusion
|
2013
|
0.84
|
|
18
|
Cytoplasmic trapping of CXCR4 in hepatocellular carcinoma cell lines.
|
Cancer Res Treat
|
2008
|
0.84
|
|
19
|
Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study.
|
Ann Hematol
|
2014
|
0.83
|
|
20
|
Differential effects of CXCR4 antagonists on the survival and proliferation of myeloid leukemia cells in vitro.
|
Korean J Hematol
|
2011
|
0.83
|
|
21
|
A multicenter retrospective analysis of the clinical features of pernicious anemia in a Korean population.
|
J Korean Med Sci
|
2013
|
0.82
|
|
22
|
Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients.
|
Ann Hematol
|
2013
|
0.81
|
|
23
|
Clinical implications of elevated antiphospholipid antibodies in adult patients with primary immune thrombocytopenia.
|
Korean J Intern Med
|
2011
|
0.80
|
|
24
|
Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience.
|
Int J Hematol
|
2011
|
0.79
|
|
25
|
Interferon gamma has dual potential in inhibiting or promoting survival and growth of hematopoietic progenitors: interactions with stromal cell-derived factor 1.
|
Int J Hematol
|
2006
|
0.79
|
|
26
|
Comparison of health-related quality of life between cancer survivors treated in designated cancer centers and the general public in Korea.
|
Jpn J Clin Oncol
|
2013
|
0.78
|
|
27
|
Korean guideline for iron chelation therapy in transfusion-induced iron overload.
|
J Korean Med Sci
|
2013
|
0.78
|
|
28
|
Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollment.
|
Jpn J Clin Oncol
|
2010
|
0.77
|
|
29
|
Endogenous stromal cell-derived factor-1 (CXCL12) supports autonomous growth of acute myeloid leukemia cells.
|
Leuk Res
|
2013
|
0.76
|
|
30
|
Long-term outcome of isolated thrombocytopenia accompanied by hypocellular marrow.
|
Korean J Hematol
|
2011
|
0.75
|
|
31
|
Expression of stromal cell-derived factor-1α is an independent risk factor for lymph node metastasis in early gastric cancer.
|
Oncol Lett
|
2011
|
0.75
|
|
32
|
VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
33
|
Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients.
|
Int J Hematol
|
2014
|
0.75
|
|
34
|
Comparative analysis of outcomes of allogeneic peripheral blood stem cell transplantation from related and unrelated donors.
|
Ann Hematol
|
2010
|
0.75
|
|
35
|
Cutaneous plasmacytoma.
|
Korean J Hematol
|
2012
|
0.75
|
|
36
|
Solitary pulmonary plasmacytoma.
|
Blood Res
|
2013
|
0.75
|
|
37
|
Comparable analysis of outcomes for allogeneic peripheral blood stem cell transplantation from matched related and matched unrelated donors in acute myeloid leukemia.
|
Acta Haematol
|
2011
|
0.75
|